women and recommended to 5% of women with high-risk medical conditions or taking a teratogenic medication. The risks of pregnancy or medication were rarely documented. CONCLUSION: While non-gynecologic specialists feel that contraceptive counseling is their responsibility, they do not routinely document counseling nor refer them to a gynecologist. OB and MFMs must provide more outreach to subspecialists who care for these women to help prevent unintended pregnancies in women at high risk of perinatal morbidity.
Hadassah Medical Center, Jerusalem, Israel OBJECTIVE: Gestational thrombocytopenia (GT) accounts for 75% of cases of thrombocytopenia in pregnancy. In most cases of GT, thrombocytopenia is mild (100-150 X 10 9 /L) and has no consequences for either the mother or the fetus. We aimed to investigate the characteristics, neonatal risk and recurrence rate of GT with a platelet count <100 X 10 9 /L. STUDY DESIGN: We reviewed the records of women who delivered during 2006-2016 at a large tertiary care university hospital, and who had platelet count <100 X 10 9 /L during pregnancy. RESULTS: Of 97 pregnancies in which platelet count lower than 100 X 10 9 /L was encountered, 66 (68%) were diagnosed as GT and 31 (32%) as new-onset immune-thrombocytopenic purpura (ITP). The proportions of women with onset of thrombocytopenia in early pregnancy (P¼0.004) and a lower maternal nadir platelet count (P¼0.01) were higher among those with new-onset ITP than GT. Neonatal thrombocytopenia (<100 X 10 9 /L) was encountered following comparable proportions of pregnancies of women with new-onset ITP and GT (16.1% vs. 10.6%, P¼0.51). Among women with GT, the rate of neonatal thrombocytopenia was higher in those who experienced antepartum bleeding (P¼0.009) and in whom the onset of thrombocytopenia was in early pregnancy (P¼0.002). Of 40 subsequent pregnancies, a recurrence of GT (<100 X 10 9 /L) was encountered in 22 (55%), with similar maternal and perinatal outcomes compared to the initial pregnancy. CONCLUSION: The risk of neonatal thrombocytopenia was substantial and similar in GT and new-onset ITP. The recurrence rate of GT was high in subsequent pregnancies.
822 The effect of surgery-to-conception interval on pregnancy outcomes after sleeve gastrectomy 
OBJECTIVE:
The optimal timing of pregnancy following bariatric surgery has not been established, with data limited regarding laparoscopic sleeve gastrectomy (LSG). We aimed to explore associations of the surgery-to-conception interval with pregnancy outcomes after LSG. STUDY DESIGN: We assessed pregnancy outcomes in relation to the surgery-to-conception interval for all women who underwent LSG and delivered during 2006-2018 in a university hospital. RESULTS: Of 154 patients, 67 (43.5%) conceived within the first 18 months postoperatively (early pregnancy group), whereas 87 (56.5%) conceived later (late pregnancy group). The median surgery-to-conception interval was 699 [interquartile range days. Baseline characteristics were comparable between the groups. Compared to the early pregnancy group, for the late pregnancy group, gestational weight gain was higher (median 11 vs. 8 kg, P<0.001), and hemoglobin levels were lower in early pregnancy (P¼0.03) and after delivery (P¼0.02). Other maternal and perinatal outcomes were similar between the groups, including the proportions of low-birth weight (7.5 vs. 11.5%, P¼0.58) and small-forgestational-age (SGA) infants (11.9% vs. 14.9%, P¼0.64) for those who conceived within or later than 18 months after surgery. The delivery of a SGA infant was not found to associate with any of the patient characteristics assessed, including the surgery-to-conception time interval (P¼0.30) and gestational weight gain (P¼0.14). CONCLUSION: Timing of pregnancy after LSG was found not to be associated with pregnancy outcomes. Together with documentations of a similar safety profile of pregnancy occurring earlier or later in the postoperative course, these data should reassure women who wish not to delay conception following surgery. 
